| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
|
J Clin Oncol
|
2006
|
5.09
|
|
2
|
Diagnosis and management of mycosis fungoides.
|
Oncology (Williston Park)
|
2010
|
2.32
|
|
3
|
NCI SEER public-use data: applications and limitations in oncology research.
|
Oncology (Williston Park)
|
2009
|
2.01
|
|
4
|
Factors that determine academic versus private practice career interest in radiation oncology residents in the United States: results of a nationwide survey.
|
Int J Radiat Oncol Biol Phys
|
2013
|
1.97
|
|
5
|
Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin.
|
Am J Clin Oncol
|
2010
|
1.96
|
|
6
|
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer.
|
J Thorac Oncol
|
2010
|
1.94
|
|
7
|
The pathogenesis of mycosis fungoides.
|
N Engl J Med
|
2004
|
1.78
|
|
8
|
Transimmunization for cutaneous T cell lymphoma: a Phase I study.
|
Leuk Lymphoma
|
2006
|
1.72
|
|
9
|
Population based cancer registry analysis of primary tracheal carcinoma.
|
Am J Clin Oncol
|
2011
|
1.71
|
|
10
|
Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma.
|
J Am Acad Dermatol
|
2007
|
1.70
|
|
11
|
A retrospective review of 1349 cases of sebaceous carcinoma.
|
Cancer
|
2009
|
1.70
|
|
12
|
Management of mycosis fungoides: Part 2. Treatment.
|
Oncology (Williston Park)
|
2003
|
1.57
|
|
13
|
The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry.
|
J Clin Oncol
|
2005
|
1.57
|
|
14
|
Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005.
|
Cancer J
|
2007
|
1.46
|
|
15
|
Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.44
|
|
16
|
Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
|
Cancer J
|
2006
|
1.41
|
|
17
|
Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications.
|
Cancer J
|
2004
|
1.39
|
|
18
|
Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group.
|
J Am Acad Dermatol
|
2002
|
1.29
|
|
19
|
The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database.
|
Cancer
|
2007
|
1.21
|
|
20
|
The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand?
|
J Clin Oncol
|
2010
|
1.20
|
|
21
|
Stereotactic body radiotherapy for central lung tumors.
|
J Thorac Oncol
|
2012
|
1.18
|
|
22
|
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy.
|
Am J Clin Oncol
|
2011
|
1.16
|
|
23
|
Superior vena cava syndrome--a proposed classification system and algorithm for management.
|
J Thorac Oncol
|
2008
|
1.16
|
|
24
|
Total skin electron beam radiotherapy for patients who have mycosis fungoides.
|
Hematol Oncol Clin North Am
|
2003
|
1.13
|
|
25
|
Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.11
|
|
26
|
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.06
|
|
27
|
Primary cutaneous T-cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T-cell lymphoma.
|
Arch Dermatol
|
2009
|
1.06
|
|
28
|
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance.
|
Curr Probl Cancer
|
2012
|
1.04
|
|
29
|
Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
|
J Clin Oncol
|
2004
|
1.02
|
|
30
|
Radiation oncology, resident research, and the American Board of Radiology Holman Pathway.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.01
|
|
31
|
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database.
|
Lung Cancer
|
2008
|
0.99
|
|
32
|
FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma.
|
Mol Imaging Biol
|
2008
|
0.97
|
|
33
|
Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database.
|
J Thorac Oncol
|
2015
|
0.94
|
|
34
|
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).
|
J Am Acad Dermatol
|
2010
|
0.94
|
|
35
|
Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty.
|
Acad Med
|
2014
|
0.93
|
|
36
|
Details and difficulties regarding the new lung cancer staging system.
|
Chest
|
2010
|
0.92
|
|
37
|
Cutaneous lymphoma.
|
Curr Probl Cancer
|
2008
|
0.91
|
|
38
|
Limitations and biases of the Surveillance, Epidemiology, and End Results database.
|
Curr Probl Cancer
|
2012
|
0.91
|
|
39
|
Geographic analysis of the radiation oncology workforce.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.91
|
|
40
|
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.
|
J Thorac Oncol
|
2015
|
0.90
|
|
41
|
Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex.
|
Am J Clin Oncol
|
2013
|
0.90
|
|
42
|
Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results database.
|
J Clin Oncol
|
2008
|
0.89
|
|
43
|
Success breeds success: authorship distribution in the Red Journal, 1975-2011.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.88
|
|
44
|
Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT).
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.87
|
|
45
|
Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
|
Oncology (Williston Park)
|
2003
|
0.87
|
|
46
|
National Residency Matching Program (NRMP) results for radiation oncology: 2011 update.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.86
|
|
47
|
Regarding adjuvant radiation therapy in merkel cell carcinoma: selection bias and its affect on overall survival.
|
J Clin Oncol
|
2007
|
0.86
|
|
48
|
Plasma cell problems: Case 1. Disseminated cutaneous plasmacytomas treated with total skin electron radiotherapy.
|
J Clin Oncol
|
2005
|
0.86
|
|
49
|
A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.85
|
|
50
|
Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma.
|
Clin Cancer Res
|
2004
|
0.85
|
|
51
|
National residency matching program results for radiation oncology: 2012 update.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.85
|
|
52
|
A prognostic index for predicting lymph node metastasis in minor salivary gland cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.84
|
|
53
|
Nutritional support of patients undergoing radiation therapy for head and neck cancer.
|
Oncology (Williston Park)
|
2005
|
0.83
|
|
54
|
Resident-reported brachytherapy experience in ACGME-accredited radiation oncology training programs.
|
Brachytherapy
|
2013
|
0.82
|
|
55
|
Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
|
Am J Clin Oncol
|
2009
|
0.82
|
|
56
|
Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx.
|
Cancer J
|
2004
|
0.82
|
|
57
|
Cutaneous lymphomas.
|
Semin Radiat Oncol
|
2007
|
0.82
|
|
58
|
Matching the dosimetry characteristics of a dual-field Stanford technique to a customized single-field Stanford technique for total skin electron therapy.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.82
|
|
59
|
Central neurologic involvement in mycosis fungoides: ten cases, actuarial risk assessment, and predictive factors.
|
Cancer J
|
2006
|
0.82
|
|
60
|
Advances in radiotherapy for lung cancer.
|
Semin Respir Crit Care Med
|
2008
|
0.82
|
|
61
|
The role of radiation therapy in malignant thymoma: a Surveillance, Epidemiology, and End Results database analysis.
|
J Thorac Oncol
|
2010
|
0.82
|
|
62
|
Total skin electron beam therapy and cutaneous T-cell lymphoma: a clinical guide for patients and staff.
|
Dermatol Nurs
|
2004
|
0.81
|
|
63
|
Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.81
|
|
64
|
Postoperative radiation therapy for non-small cell lung cancer.
|
Semin Thorac Cardiovasc Surg
|
2008
|
0.80
|
|
65
|
Disseminated herpes simplex after total skin electron beam radiotherapy for mycosis fungoides.
|
J R Soc Med
|
2003
|
0.80
|
|
66
|
ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.
|
Curr Probl Cancer
|
2010
|
0.79
|
|
67
|
Effects of breast-conserving therapy on lactation after pregnancy.
|
Cancer J
|
2005
|
0.79
|
|
68
|
CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature.
|
Leuk Lymphoma
|
2015
|
0.79
|
|
69
|
Scholastic activity among radiation oncology residents at US academic institutions: a benchmark analysis.
|
J Cancer Educ
|
2013
|
0.78
|
|
70
|
The American Board of Radiology Holman Research Pathway: 10-year retrospective review of the program and participant performance.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.78
|
|
71
|
Clinical implementation of prostate image guided radiation therapy: a prospective study to define the optimal field of interest and image registration technique using automated x-ray volumetric imaging software.
|
Technol Cancer Res Treat
|
2008
|
0.78
|
|
72
|
Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities.
|
Oncology (Williston Park)
|
2006
|
0.78
|
|
73
|
Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI Surveillance, Epidemiology, and End Results database.
|
Cancer
|
2008
|
0.77
|
|
74
|
Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes.
|
Curr Probl Cancer
|
2012
|
0.77
|
|
75
|
Role of radiotherapy in the management of merkel cell carcinoma of the skin.
|
J Natl Compr Canc Netw
|
2006
|
0.77
|
|
76
|
Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
|
J Am Acad Dermatol
|
2013
|
0.77
|
|
77
|
Research funding for radiation oncology: an unfortunately small sliver of an inadequate pie.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.76
|
|
78
|
Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?
|
Int J Clin Oncol
|
2013
|
0.76
|
|
79
|
ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II.
|
J Am Coll Radiol
|
2011
|
0.76
|
|
80
|
Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy.
|
J Clin Oncol
|
2005
|
0.75
|
|
81
|
Eosinophilia: outcomes and bias.
|
J Am Acad Dermatol
|
2005
|
0.75
|
|
82
|
Lentigo maligna and radiotherapy.
|
N Engl J Med
|
2006
|
0.75
|
|
83
|
Primary cutaneous B-cell lymphoma.
|
J Clin Oncol
|
2006
|
0.75
|
|
84
|
Do PET and SNB reduce the rate of elective neck dissection? A hypothesis still in need of validation.
|
J Clin Oncol
|
2005
|
0.75
|
|
85
|
Delivery and sequelae of total skin electron beam therapy.
|
Arch Dermatol
|
2003
|
0.75
|
|
86
|
Cutaneous lymphomas: one size does not fit all.
|
Cancer J
|
2009
|
0.75
|
|
87
|
Skin cancers after organ transplantation.
|
N Engl J Med
|
2003
|
0.75
|
|
88
|
The prognostic importance of midline involvement in oral tongue cancer.
|
Am J Clin Oncol
|
2012
|
0.75
|
|
89
|
National Residency Matching Program results for radiation oncology: 2006 update.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.75
|
|
90
|
National Residency Matching Program (NRMP) results for radiation oncology, 2004 update.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.75
|
|
91
|
Prediction models, nomograms, and staging validation with the Surveillance, Epidemiology, and End Results database: using Surveillance, Epidemiology and End Results (SEER) program to create prediction models.
|
Curr Probl Cancer
|
2012
|
0.75
|
|
92
|
The effect of age on prostate implantation results.
|
Cancer J
|
2006
|
0.75
|
|
93
|
American Radium Society 92nd Annual Meeting.
|
Expert Rev Anticancer Ther
|
2010
|
0.75
|
|
94
|
Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type.
|
Am J Clin Oncol
|
2017
|
0.75
|
|
95
|
Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results database: what is Comparative Effectiveness Research (CER) and why is it important?
|
Curr Probl Cancer
|
2012
|
0.75
|
|
96
|
Mycosis fungoides exhibiting features of a dermatofibroma: a case report and review of the literature.
|
J Cutan Pathol
|
2011
|
0.75
|
|
97
|
Postoperative radiation therapy for lung cancer: where do we stand?
|
Oncology (Williston Park)
|
2008
|
0.75
|
|
98
|
Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy.
|
Oncology (Williston Park)
|
2006
|
0.75
|
|
99
|
National residency matching program (NRMP) results for radiation oncology: 2010 update.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.75
|
|
100
|
National Residency Matching Program (NRMP) results for radiation oncology: 2007 update.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.75
|